JDDonline

Explore the Journal of Drugs in Dermatology (JDD), a monthly peer-reviewed, PubMed® indexed dermatology journal & online resource.

Complimentary subscriptions for US dermatologists, dermatology residents, nurse practitioners and physician assistants.

Early Online

CURRENT ISSUE HIGHLIGHTS

Readability and Content Characterization of Online Reading Materials for Individuals With Vitiligo

Published online March 31, 2025

To the Editor: Online health resources expand availability of medical information, however, if written at a reading level that is too advanced, may ...

read more
Artificial Intelligence-Generated Educational Curriculum on Facial Neurotoxin Injections: Assessment of Educational Content, Curriculum Structure, and Course Logistics

Published online March 31, 2025

ChatGPT (OpenAI, San Francisco, California) is a novel artificial intelligence (AI) large language model (LLM) that has garnered signif...

read more
Clinical Utility of TRPV1 Modulation for Skincare Sensitivity

Published online March 31, 2025

Transient receptor potential vanilloid 1 protein (TRPV1) first became significant because of its ability to modulate peripheral sensory...

read more
Top Chief Complaints and Diagnoses for Outpatient Dermatology Patients of Color

Published online March 30, 2025

While people with skin of color in the United States (US) are projected to become the majority of the population by 2044, research and...

read more
The State of the Clinical Management Union: A Cross-Sectional Survey of Persons With Hidradenitis Suppurativa

Published online March 28, 2025

Hidradenitis suppurativa (HS) is a chronic auto-inflammatory condition characterized by the presence of fluctuant, painful papules an...

read more
An Algorithm Integrating Acneceuticals into the Management of Acne Vulgaris

Published online March 28, 2025

Although many quality prescription products exist for the treatment of acne, we continue to search for ways to improve patient ca...

read more
Off-Label Management Strategies for Generalized Granuloma Annulare: What’s New?

Published online March 24, 2025

Granuloma annulare (GA) is a benign, inflammatory granulomatous skin disease with an estimated annualized prevalence of ~0.06% in...

read more
The Utility of Oral Polypodium Leucotomos Extract for Dermatologic Diseases: A Systematic Review

Published online March 28, 2025

Polypodium leucotomos is a South American fern rich in antioxidants that produces polypodium leucotomos extract (PLE) from its ...

read more
Rituximab in the Treatment of Epidermolysis Bullosa Acquisita: A Systematic Review of the Literature

Published online March 28, 2025

Epidermolysis bullosa acquisita (EBA) is a rare autoimmune blistering disorder caused by autoantibodies targeting type VII collagen...

read more
An Innovative Cream Improves Signs and Symptoms of Dermatoporosis in Patients Aged 65 and Over

Published online March 17, 2025

Dermatoporosis describes thin, aged, and excessively fragile skin resulting from loss of the skin's protective mechanical function. 1 ...

read more
Racial and Ethnic Representation in Atopic Dermatitis Clinical Trials

Published online March 14, 2025

Atopic dermatitis (AD) is the most common chronic inflammatory skin disorder globally, with an estimated prevalence of 31.6 million peo...

read more
Acetyl Hexapeptide-8 as a Topical Alternative to Botulinum Toxin: A Review of the Literature

Published online March 12, 2025

Acetyl hexapeptide-8, marketed as Argireline ® (Lipotec, Barcelona, Spain), is a six-amino-acid biomimetic of botulinum toxin prom...

read more
Single-Center, Open-Label Study Study to Evaluate Improvement of Hair Appearance With Novel Hair Growth Serum

Published online March 12, 2025

Hair loss is a prevalent issue affecting both men and women, often leading to considerable psychological distress. The causes of ha...

read more
Effects of a Moisturizer Containing Colloidal Oatmeal and Filaggrin Technology on Staphylococcus Species In Vitro

Published online March 12, 2025

Atopic dermatitis (AD) is a multifactorial disease associated with both genetic risk factors and environmental stimuli. AD is also ass...

read more

Current Issue

Explore JDDonline
Subscribe to JDD

Discover the latest research, exclusive articles from leading dermatology experts – Subscribe to the JDD today. Complimentary subscriptions available for US dermatologists, dermatology residents, dermatology nurse practitioners & physician assistants.

Subscribe Now

Latest News

Touching on Tailored Topical for Tons of Tough Treatment Tchallenges

| Featured Articles, Featured Podcast, Podcast Highlights, The Latest | No Comments
Featured Podcast Even in a world of exponentially expanding systemic options both on and off label, one fact remains: topical therapy is ALWAYS on the menu. With an unprecedented array…
Journal of Drugs in Dermatology JDD About Spesolimab for the Treatment of Generalized Pustular Psoriasis Flares

Spesolimab for the Treatment of Generalized Pustular Psoriasis Flares

| Featured Articles, Latest News, Psoriasis, The Latest | No Comments
Did you miss this March article? Generalized pustular psoriasis (GPP) is a serious and unpredictable skin condition with limited treatment options. The Effisayil 1 trial evaluated spesolimab, a monoclonal antibody…
Journal of Drugs in Dermatology JDD About Latin America Cutaneous Oncology Management (LACOM) I: The Role of Skin Care in Oncology Patients and Survivors

Latin America Cutaneous Oncology Management (LACOM) I: The Role of Skin Care in Oncology Patients and Survivors

| Featured Articles, Latest News, Oncodermatology, The Latest | No Comments
Prioritizing Skincare in Cancer Treatment: A Latin American Initiative Cancer treatments often lead to skin-related side effects that impact quality of life and, in some cases, treatment adherence. The Latin…
Journal of Drugs in Dermatology JDD About Artificial Intelligence-Based Personalization of Treatment Regimen for Hair Loss: A 6-Month Clinical Trial

Artificial Intelligence-Based Personalization of Treatment Regimen for Hair Loss: A 6-Month Clinical Trial

| Alopecia, Featured Articles, Hair, Latest News, The Latest | No Comments
AI-Powered Personalization for Hair Loss: A Promising Alternative? With up to 50% of women and 80% of men experiencing hair loss, many turn to generic over-the-counter solutions—often with disappointing results.…
Journal of Drugs in Dermatology JDD About Efficacy and Safety of Micronized Isotretinoin Administered Once Daily Without Food in Patients With Recalcitrant Nodular Acne. Image from The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas of a darker skin tone patient with acne.

Efficacy and Safety of Micronized Isotretinoin Administered Once Daily Without Food in Patients With Recalcitrant Nodular Acne

| Acne, Featured Articles, Latest News, The Latest | No Comments
Did You Miss It? Micronized isotretinoin is an established treatment for severe nodular acne, but can it be effectively dosed once daily instead of twice? A new pilot study explores…
Journal of Drugs in Dermatology JDD About Lichen Planus Pigmentosus. Image from the Full Spectrum of Dermatology: A Diverse and Inclusive Atlas of a person with a darker skin tone with LPP.

Cracking the Code of Lichen Planus Pigmentosus

| Dyspigmentation, Featured Articles, Latest News, The Latest | No Comments
Articles from the Archives Lichen planus pigmentosus (LPP) remains one of dermatology’s most enigmatic conditions—often presenting insidiously, confounding diagnoses, and challenging treatment plans. Whether it appears as diffuse gray-brown patches…
View all Derm News

News Topics

JDD Newsletter

Sign up for the JDD eNewsletter for exclusive articles, case reports, Podcast episodes, free CME activities, and more!

Subscribe

JDD Podcast

Who Wore (or taught) It Better: An Critical Appraisal of AI Generated Answers to Patient Questions About Mohs Surgery

| Dermatology Podcast Archives, Featured Podcast, JDD Highlights, Podcast Highlights | No Comments
iTunes TuneIn Spotify Dr. Vishal Patel and Kennedy Sun "Come with me if you want to live." That iconic statement from Arnold Schwarzenegger in T2 couldn't be more true today; if you…
Tune In

Follow Us